Gemzar is a nucleoside metabolic inhibitor indicated: \u2022 in combination with carboplatin, for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinumbased therapy \u2022 in combination with paclitaxel, for first-line treatment of metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated \u2022 in combination with cisplatin for the treatment of non-small cell lung cancer \u2022 as a single agent for the treatment of pancreatic cancer<\/p>\n
If Gemcitabine for injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
Note:<\/strong><\/em> Gemcitabine hydrochloride is a type of chemotherapy called an antimetabolite. It kills cancer cells and other rapidly growing cells by preventing them from making DNA and RNA.<\/p>\n Approval Date: 1996 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cGemcitabine for injection\u201d based on the information you provide.<\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996<\/h2>\n
Facts about Gemcitabine for injection<\/h4>\n
\nProprietary Name: On Request
\nActive Ingredient(s): Gemcitabine for injection
\nDosage Forms And Strengths: Capsules:\u00a0 \u2022 200 mg\/single-use vial \u2022 1 g\/single-use vial
\nCompany: Eli Lilly and Company
\nCurrent indications: non-small cell lung cancer; NSCLC<\/b>
\nMedicine Approved By: \u2013<\/strong>\u00a0European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
\nSummary of FDA approved use on approval date:<\/strong>\u00a0Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n